We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Loews
L
$22.1B
| $107 | ﹤0.01% |
+1
| New | +$107 |
2026 Q1
0 quarters
|
|
902
Caris Life Sciences
CAI
$8.79B
| $107 | ﹤0.01% |
+6
| New | +$131 |
2026 Q1
0 quarters
|
|
903
Harrow
HROW
$1.05B
| $106 | ﹤0.01% |
+3
| New | +$132 |
2026 Q1
0 quarters
|
|
904
DELISTED
Coterra Energy
CTRA
| $105 | ﹤0.01% |
+3
| New | +$90 |
2026 Q1
0 quarters
|
|
905
State Street Financial Select Sector SPDR ETF
XLF
$50.4B
| $99 | ﹤0.01% |
2
-116,764
| -100% | -$6.08M |
2025 Q4
1 quarter
|
|
906
Cable One
CABO
$53.1M
| $91 | ﹤0.01% |
+1
| New | +$98 |
2026 Q1
0 quarters
|
|
907
NCR Atleos
NATL
$3.38B
| $87 | ﹤0.01% |
+2
| New | +$83 |
2026 Q1
0 quarters
|
|
908
Brady Corp
BRC
$3.97B
| $81 | ﹤0.01% |
+1
| New | +$87 |
2026 Q1
0 quarters
|
|
909
Corcept Therapeutics
CORT
$13B
| $81 | ﹤0.01% |
+2
| New | +$75 |
2026 Q1
0 quarters
|
|
910
Karman Holdings
KRMN
$3.97B
| $80 | ﹤0.01% |
+1
| New | +$96 |
2026 Q1
0 quarters
|
|
911
Vista Energy
VIST
$7.67B
| $75 | ﹤0.01% |
+1
| New | +$58 |
2026 Q1
0 quarters
|
|
912
Central Bancompany Inc
CBC
$7.75B
| $72 | ﹤0.01% |
3
-149,997
| -100% | -$3.63M |
2025 Q4
1 quarter
|
|
913
Dime Commercial Bancshares
DCOM
$1.68B
| $68 | ﹤0.01% |
+2
| New | +$66 |
2026 Q1
0 quarters
|
|
914
Ategrity Specialty Insurance
ASIC
$1.24B
| $59 | ﹤0.01% |
3
-113,847
| -100% | -$2.2M |
2025 Q2
3 quarters
|
|
915
Centerspace
CSR
$932M
| $57 | ﹤0.01% |
+1
| New | +$63 |
2026 Q1
0 quarters
|
|
916
DELISTED
SkyWater Technology
SKYT
| $55 | ﹤0.01% |
+2
| New | +$59 |
2026 Q1
0 quarters
|
|
917
DELISTED
Janus Henderson
JHG
| $51 | ﹤0.01% |
+1
| New | +$50 |
2026 Q1
0 quarters
|
|
918
Stepan Co
SCL
$1.41B
| $50 | ﹤0.01% |
+1
| New | +$54 |
2026 Q1
0 quarters
|
|
919
DELISTED
Thermon Group Holdings
THR
| $50 | ﹤0.01% |
+1
| New | +$47 |
2026 Q1
0 quarters
|
|
920
Hut 8
HUT
$9.41B
| $47 | ﹤0.01% |
+1
| New | +$54 |
2026 Q1
0 quarters
|
|
|
MRX
921
Marex Group Limited Ordinary Shares
MRX
$5.15B
| $45 | ﹤0.01% |
+1
| New | +$39 |
2026 Q1
0 quarters
|
|
922
DELISTED
Day One Biopharmaceuticals
DAWN
| $43 | ﹤0.01% |
+2
| New | +$28 |
2026 Q1
0 quarters
|
|
923
Helen of Troy
HELE
$670M
| $43 | ﹤0.01% |
+3
| New | +$52 |
2026 Q1
0 quarters
|
|
924
Southwest Airlines
LUV
$19.4B
| $38 | ﹤0.01% |
1
-84,932
| -100% | -$3.84M |
2025 Q4
1 quarter
|
|
925
SI-BONE Inc
SIBN
$882M
| $38 | ﹤0.01% |
+3
| New | +$47 |
2026 Q1
0 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.